Prasugrel

• Mechanism of Action
• Irreversibly inhibits the binding of adenosine diphosphate (ADP) to platelet P2Y₁₂ receptors, resulting in reduced platelet activation and aggregation.
• • Pharmacology
  • A pro-drug that requires enzymatic activation.

Clinical Use

• • Indications
• • Contraindications
• • Adverse Effects
  • Haemorrhage.